Literature DB >> 15358341

Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts.

Rubens Fraga Alves Pinto1, Maria de Lourdes Higuchi, Vera Demarchi Aiello.   

Abstract

INTRODUCTION: In the primary form of pulmonary hypertension (PH), the involvement of inflammation in the physiopathology of the vascular lesions is well established. Its role in secondary PH is yet to be investigated. We quantified the inflammatory cells on the walls of peripheral pulmonary arteries from patients with congenital heart shunts.
METHODS: Twenty-six lung biopsies from patients with increased pulmonary flow and 10 lung fragments from control participants were examined. B-lymphocytes (CD20), T-lymphocytes (CD3), recently recruited macrophages (MAC387) and granulocytes (CD15) were quantified by area of the adventitia in arteries >50 microm. An index of inflammatory cells infiltrating the medial and intimal layers was also determined.
RESULTS: There was no difference in the sum of densities of adventitial inflammatory cells between the groups. A prevalence of MAC387-labeled cells was detected in the PH group and of CD3-labeled cells in the controls. There was a lower density of T-lymphocytes in the PH group (P<.004). Patients with intimal proliferative lesions showed prevalence of MAC387-labeled cells (P=.004). PH participants showed a higher index of MAC387-labeled cells infiltrating the arterial medial and intimal layers (P<.001).
CONCLUSION: The predominance of recently recruited macrophages in the PH group is compatible with ongoing inflammatory reaction in the arterial walls. This could be related to the pathogenesis of the vascular lesions, as a consequence of cytokines produced by the inflammatory cells. The smaller number of adventitial T-lymphocytes in patients with congenital shunts can reflect an impairment of their immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358341     DOI: 10.1016/j.carpath.2004.06.003

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  17 in total

1.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage.

Authors:  Maria G Frid; Jacqueline A Brunetti; Danielle L Burke; Todd C Carpenter; Neil J Davie; John T Reeves; Mark T Roedersheimer; Nico van Rooijen; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Shuxin Liang; Ankit A Desai; Stephen M Black; Haiyang Tang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.

Authors:  Ling Yan; Xinping Chen; Megha Talati; Bethany Womack Nunley; Santhi Gladson; Tom Blackwell; Joy Cogan; Eric Austin; Ferrin Wheeler; James Loyd; James West; Rizwan Hamid
Journal:  Am J Respir Crit Care Med       Date:  2016-04-15       Impact factor: 21.405

5.  Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress.

Authors:  Joanna Costa; Yan Zhu; Timothy Cox; Paul Fawcett; Thomas Shaffer; Deepthi Alapati
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.

Authors:  Wei Wang; Yu-Lin Wang; Xiao-Ying Chen; Yu-Tang Li; Wei Hao; You-Peng Jin; Bo Han
Journal:  Mol Biol Rep       Date:  2011-03-23       Impact factor: 2.316

7.  CD4+ T cells and IFN-γ are required for the development of Pneumocystis-associated pulmonary hypertension.

Authors:  Steve D Swain; Dan W Siemsen; Rebecca R Pullen; Soo Han
Journal:  Am J Pathol       Date:  2013-12-21       Impact factor: 4.307

Review 8.  The adventitia: Essential role in pulmonary vascular remodeling.

Authors:  Kurt R Stenmark; Eva Nozik-Grayck; Evgenia Gerasimovskaya; Adil Anwar; Min Li; Suzette Riddle; Maria Frid
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

9.  Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment.

Authors:  Danielle L Burke; Maria G Frid; Claudia L Kunrath; Vijaya Karoor; Adil Anwar; Brandie D Wagner; Derek Strassheim; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

10.  Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Authors:  Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.